Search Result "PCSK9 inhibitor"
PCSK9 Inhibitors and Cardiovascular Disease: Impact on Cardiovascular Outcomes
Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 2 Year: 2020 Page: 138-146
Author(s): Paraskevi Farmaki,Christos Damaskos,Nikolaos Garmpis,Anna Garmpi,Spyridon Savvanis,Evangelos Diamantis
Dyslipidaemias and Cardiovascular Disease: Focus on the Role of PCSK9 Inhibitors
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 27 Year: 2020 Page: 4494-4521
Author(s): Olga Panagiotopoulou,Scott T. Chiesa,Dimitrios Tousoulis,Marietta Charakida
PCSK9 and Hypercholesterolemia: Therapeutic Approach
Journal: Current Drug Targets
Volume: 19 Issue: 9 Year: 2018 Page: 1058-1067
Author(s): Milan Obradovic,Bozidarka Zaric,Emina Sudar-Milovanovic,Branislava Ilincic,Edita Stokic,Milan Perovic,Esma R. Isenovic
A Review of PCSK9 Inhibitors and their Effects on Cardiovascular Diseases
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 20 Year: 2019 Page: 1790-1817
Author(s): Bo Chen,Xin Shi,Yanping Cui,Aiping Hou,Pengjun Zhao
PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 165-176
Author(s): Yan Wang,Zhao-Peng Liu
The Role of PCSK9 in the Pathogenesis of Non-alcoholic Fatty Liver Disease and the Effect of PCSK9 Inhibitors
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3654-3657
Author(s): Eleni Theocharidou,Marianna Papademetriou,Andromachi Reklou,Alexandros Sachinidis,Chrisoula Boutari,Olga Giouleme
Pharmacology of PCSK9 Inhibitors: Current Status and Future Perspectives
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3622-3633
Author(s): Aikaterini N. Tsouka,Constantinos C. Tellis,Alexandros D. Tselepis
Roles of PCSK9 in the Pathogenesis of Periodontal Disease
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 39 Year: 2024 Page: 6429-6435
Author(s):
PCSK9 Inhibitors: From Natureâs Lessons to Clinical Utility
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 6 Year: 2020 Page: 840-854
Author(s): Frederick J. Raal,Robert Chilton,Naresh Ranjith,Virendra Rambiritch,Rory F. Leisegang,Iftikhar O. Ebrahim,Alet van Tonder,Nelusha Shunmoogam,Célia Bouharati,Moji G. Musa,Sumanth Karamchand,Poobalan Naidoo,Dirk J. Blom
PCSK9 Inhibition-Based Therapeutic Approaches: An ImmunotherapyPerspective
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 6 Year: 2022 Page: 980-999
Author(s): Amirhossein Sahebkar,Suowen Xu,Matteo Pirro,Amir Abbas Momtazi-Borojeni